Lawrence Otto Klein - Insider Trading & Ownership

Location
C/O Crispr Therapeutics Ag, 610 Main Street 7 Th Floor, Cambridge, MA
Summary
The estimated net worth of Lawrence Otto Klein is at least $4.46M dollars as of May 1, 2025. Lawrence Otto Klein is the Chief Executive Officer, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $2.54M. Lawrence Otto Klein is the CBO & COO of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $1.67M. Lawrence Otto Klein is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $229K. Lawrence Otto Klein is the Director of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $15.9K.
Signature
/s/ Elizabeth Balta, as attorney-in-fact for Lawrence Otto Klein
All Insider Reports
All Insider Reports

Ownership of Lawrence Otto Klein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORKA Oruka Therapeutics, Inc. Chief Executive Officer, Director $2.54M Jan 22, 2025
CRSP CRISPR Therapeutics AG Cbo & Coo $1.67M Aug 16, 2022
JBIO Jade Biosciences, Inc. Director $229K Apr 29, 2025
JSPR, JSPRW Jasper Therapeutics, Inc. Director $15.9K Jun 7, 2023
DYN Dyne Therapeutics, Inc. Director Jul 5, 2022

Insider Transactions Reported by Lawrence Otto Klein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.